ACC AHA 2017 Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Title Cover

Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death GUIDELINES Pocket Guide

Approved By

American College of Cardiology Foundation

American Heart Association

Digital Subscription $4.99 Add to Cart
Print $17.95 Add to Cart
Free Sample

The digital subscription version of the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death GUIDELINES Pocket Guide contains all the same great information found in the physical pocket guide, and can be accessed on mobile devices and online:

  • Price: $4.99 per year
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • CPT® and ICD10 codes can be added to certain guidelines for an additional fee
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Sudden Cardiac Death GUIDELINES Pocket Guide is based on the latest guidelines of the American College of Cardiology and the American Heart Association and was developed with their collaboration. This practical quick-reference tool contains detailed, graded recommendations for prevention of sudden cardiac death. It includes multiple algorithms, ECGs and tables of definitions — medications, diagnostic tips, comorbidities and risk factors.

  • Spiral-bound
  • 29 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Graded recommendations for:
    • Syncope
    • 12-lead ECG and Exercise Testing
    • Ambulatory Electrocardiography
    • Implanted Cardiac Monitors
    • Noninvasive Cardiac Imaging
    • Assessment
    • Genetic Counselling
    • Invasive Imaging: Cardiac Catheterization
    • Electrophysiological Study
    • Pharmacological Prevention of SCD
    • Surgery and Revascularization Procedures in Patients With Ischemic Heart Disease
    • Surgery for Arrhythmia Management
    • Autonomic Modulation
    • Management of Cardiac Arrest
    • Secondary Prevention of SCD in Patients with Ischemic Heart Disease
    • Coronary Artery Spasm
    • Primary Prevention of SCD in Patients with Ischemic Heart Disease
    • Recurrent VA in Patients With Ischemic Heart Disease
    • Nonischemic Cardiomyopathy (NICM)
    • Secondary Prevention of SCD in Patients With NICM
    • Primary Prevention of SCD in Patients With NICM
    • Treatment of Recurrent VA in Patients With NICM
    • Arrhythmogenic Right Ventricular Cardiomyopathy
    • Hypertrophic Cardiomyopathy (HCM)
    • Myocarditis
    • Cardiac Sarcoidosis
    • HFr EF
    • LVAD
    • ICD Use After Heart Transplantation
    • Neuromuscular Disorders
    • Cardiac Channelopathies
    • Congenital Long QT Syndrome
    • Catecholaminergic Polymorphic Ventricular Tachycardia
    • Brugada Syndrome
    • Early Repolarization “J-wave” Syndrome
    • Short QT Syndrome
    • VA in the Structurally Normal Heart
    • Outflow Tract VA
    • Papillary Muscle VA (PVCs and VT)
    • Interfascicular Reentrant VT (Belhassen Tachycardia)
    • Idiopathic Polymorphic VT/VF
    • PVC-Induced Cardiomyopathy
    • Pregnancy
    • Older Patients With Comorbidities
    • Medication-Induced Arrhythmias
    • Adult Congenital Heart Disease
    • Subcutaneous Implantable Cardioverter-Defibrillator
    • Wearable Cardioverter-Defibrillator
    • Catheter Ablation
    • Postmortem Evaluation of SCD
    • Terminal Care
    • Shared Decision-Making
  • Tables
    • Table of Definitions of Commonly Used Terms in this Document
    • Important Considerations in the Evaluation of Patients With Known or Suspected VA
    • Pharmacological Characteristics of Available Antiarrhythmic Medications for Treating VA
    • Major Clinical Features Associated With Increased Risk of SCD in Patients With HCM
    • Neuromuscular Disorders Associated With Heart Disease
    • Commonly Used QT-Prolonging Medications
    • Congenital Heart Disease: Risk Factors for VA/SCD
  • Figures
    • SCD Incidence and Total Events
    • SCD and Clinical Subsets
    • Long-QT Syndrome Type 1 (ECG)
    • Long-QT Syndrome Type 2 (ECG)
    • Long-QT Syndrome Type 3 (ECG)
    • Exercise-Induced Polymorphic VT in Catecholaminergic Polymorphic Ventricular Tachycardia (ECG)
    • Brugada Syndrome (ECG)
    • Incremental Cost-Effectiveness of ICD by Years of Life Added (Example)
  • Algorithms
    • Management of Sustained Monomorphic VT
    • Secondary Prevention in Patients With Ischemic Heart Disease
    • Primary Prevention of SCD in Patients With Ischemic Heart Disease
    • Treatment of Recurrent VA in Patients With Ischemic Heart Disease or NICM
    • Secondary and Primary Prevention of SCD in Patients With NICM
    • Prevention of SCD in Patients With HCM
    • Prevention of SCD in Patients With Cardiac Sarcoidosis
    • Prevention of SCD in Patients With Long QT Syndrome
    • Prevention of SCD in Patients With Brugada Syndrome
    • Prevention of SCD in Patients With Long QT Syndrome
    • Prevention of SCD in Patients With Adult Congenital Heart Disease

The American College of Cardiology (ACC) continues to transform quality cardiovascular care and improve heart health after more than 60 years of existence through its mission, vision and values. The College is proud of its efforts to bring evidence-based clinical care into everyday practice.

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. AHA's Professional Membership is a made up of a robust group of cardiovascular professionals who participate in discovery and dissemination of science.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year